440 studies found for:    "Lupus"
Show Display Options
RSS Create an RSS feed from your search for:
"Lupus"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
Conditions: Cutaneous Lupus;   Discoid Lupus;   Lupus;   Systemic Lupus Erythematosus
Interventions: Drug: AMG811;   Drug: AMG811 Placebo
2 Completed Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
Conditions: Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic
Interventions: Drug: R932333;   Drug: Placebo
3 Completed A Non-drug Study Profiling Cutaneous Lupus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic;   Lupus Erythematosus, Discoid
Interventions: Procedure: No intervention, skin biopsy;   Procedure: No intervention, blood collection;   Procedure: No intervention, urine collection
4 Recruiting A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic;   Lupus Erythematosus, Discoid;   Healthy
Interventions: Procedure: Skin biopsy;   Procedure: Blood collection;   Procedure: Urine collection
5 Completed Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease
Conditions: Immunologic Diseases;   Autoimmune Diseases;   Systemic Lupus Erythematosus;   Lupus Nephritis;   Lupus Glomerulonephritis
Intervention: Drug: Abetimus sodium (LJP 394)
6 Completed Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: CTLA4-IgG4m (RG2077);   Drug: Cyclophosphamide
7 Unknown  Cutaneous Lupus Erythematosus and Elidel
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid
Intervention: Drug: Elidel (pimecrolimus)
8 Completed
Has Results
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
Conditions: Lupus Nephritis;   Lupus Erythematosus, Systemic
Interventions: Drug: abatacept;   Drug: cyclophosphamide;   Drug: azathioprine;   Drug: prednisone;   Drug: abatacept placebo;   Drug: azathioprine placebo
9 Terminated Study of LJP 394 in Lupus Patients With History of Renal Disease
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: abetimus sodium (LJP 394) and/or placebo solution;   Drug: abetimus sodium (LJP 394);   Drug: Phosphate-buffered saline
10 Recruiting Duke Lupus Registry
Conditions: Systemic Lupus Erythematosus;   Cutaneous Lupus
Intervention:
11 Terminated Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva
Condition: Discoid Lupus Erthematosus of the Scalp.
Intervention: Drug: Raptiva (efalizumab)
12 Completed Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
Conditions: Glomerulonephritis;   Lupus Nephritis;   Systemic Lupus Erythematosus
Intervention: Drug: SQ Fludarabine
13 Completed Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study
Conditions: Systemic Lupus Erythematosus;   Lupus Nephritis
Interventions: Drug: Cyclosporine A;   Drug: Cyclophosphamide
14 Withdrawn Velcade for Proliferative Lupus Nephritis
Conditions: Lupus Nephritis;   Proteinuria;   Hematuria
Intervention: Drug: Velcade
15 Terminated TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: infliximab;   Drug: placebo
16 Completed A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic
Interventions: Drug: 1 mg/kg CNTO 136;   Drug: 4 mg/kg CNTO 136;   Drug: 10 mg/kg CNTO 136;   Drug: Placebo
17 Completed Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients
Condition: Discoid Lupus Erythematosus
Intervention: Drug: CC-10004
18 Completed Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
Conditions: Lupus Nephritis;   Lupus Erythematosus, Systemic
Intervention: Drug: tacrolimus
19 Recruiting ACTHar in the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: CellCept;   Drug: Acthar gel
20 Active, not recruiting A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)
Conditions: Lupus Nephritis;   Systemic Lupus Erythematosus
Interventions: Drug: corticosteroids;   Drug: cyclophosphamide;   Drug: mycophenolate mofetil;   Drug: ocrelizumab;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years